Intervention not reported
Adverse events-serious Fluticasone/salmeterol (FPS) versus fluticasone (FP) · patients with COPD
The intervention showed no clear difference in adverse events-serious Fluticasone/salmeterol (FPS) versus… (low certainty).
1 finding from 1 review
- Combined corticosteroid and long‐acting beta₂‐agonist in one inhaler versus inhaled corticosteroids alone for chronic… 2013 · Cochrane Headline outcomes onlyOR 1.05 [0.82, 1.34]7 studies · 5055 participantsLow